RU93004915A - Липосомы, осуществляющие тимус-зависимую помощь "слабым" антигенам, используемым для приготовления вакцины - Google Patents

Липосомы, осуществляющие тимус-зависимую помощь "слабым" антигенам, используемым для приготовления вакцины

Info

Publication number
RU93004915A
RU93004915A RU93004915/14A RU93004915A RU93004915A RU 93004915 A RU93004915 A RU 93004915A RU 93004915/14 A RU93004915/14 A RU 93004915/14A RU 93004915 A RU93004915 A RU 93004915A RU 93004915 A RU93004915 A RU 93004915A
Authority
RU
Russia
Prior art keywords
liposomes
antigenes
thymus
weak
implementing
Prior art date
Application number
RU93004915/14A
Other languages
English (en)
Other versions
RU2107493C1 (ru
Inventor
Х.Р. Сикс
Н. Гаркон
Original Assignee
Рисерч Дивелопмент Фаундейшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Рисерч Дивелопмент Фаундейшн filed Critical Рисерч Дивелопмент Фаундейшн
Priority claimed from PCT/US1991/005231 external-priority patent/WO1992002243A1/en
Publication of RU93004915A publication Critical patent/RU93004915A/ru
Application granted granted Critical
Publication of RU2107493C1 publication Critical patent/RU2107493C1/ru

Links

Claims (1)

  1. Иммунный ответ на целевой антиген может быть усилен путем введения антигена в липосому вместе с дополнительным компонентом, содержащим по крайней мере один сайт узнавания Т - лимфоцита - хелпера. Липосомы могут включать в себя липидные материалы широкого ряда. Антиген и компонент, содержащий сайт узнавания Т - лимфоцита - хелпера, могут быть ассоциированы с липосомой посредством гидрофобных взаимодействий или ковалентного связывания с липидом.
RU93004915A 1990-07-27 1991-07-24 Липосомы, осуществляющие тимус-зависимую помощь "слабым" антигенам, используемым для приготовления вакцины RU2107493C1 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US55896090A 1990-07-27 1990-07-27
US558,960 1990-07-27
US558960 1990-07-27
PCT/US1991/005231 WO1992002243A1 (en) 1990-07-27 1991-07-24 Liposomes that provide thymic dependent help to weak vaccine antigens

Publications (2)

Publication Number Publication Date
RU93004915A true RU93004915A (ru) 1996-02-20
RU2107493C1 RU2107493C1 (ru) 1998-03-27

Family

ID=24231699

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93004915A RU2107493C1 (ru) 1990-07-27 1991-07-24 Липосомы, осуществляющие тимус-зависимую помощь "слабым" антигенам, используемым для приготовления вакцины

Country Status (22)

Country Link
US (1) US5464630A (ru)
EP (1) EP0542923B1 (ru)
JP (1) JP3518866B2 (ru)
KR (1) KR100213851B1 (ru)
CN (1) CN1032236C (ru)
AT (1) ATE157537T1 (ru)
AU (1) AU650299B2 (ru)
CA (1) CA2088163C (ru)
DE (1) DE69127545T2 (ru)
DK (1) DK0542923T3 (ru)
ES (1) ES2106088T3 (ru)
FI (1) FI107515B (ru)
GR (1) GR3025377T3 (ru)
HK (1) HK1008304A1 (ru)
IE (1) IE912535A1 (ru)
IL (1) IL98935A (ru)
NO (1) NO311167B1 (ru)
NZ (1) NZ239072A (ru)
PT (1) PT98470B (ru)
RU (1) RU2107493C1 (ru)
WO (1) WO1992002243A1 (ru)
ZA (1) ZA915755B (ru)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5879685A (en) * 1991-05-08 1999-03-09 Schweiz, Serum- & Impfinstitut Bern Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them
US6004534A (en) * 1993-07-23 1999-12-21 Massachusetts Institute Of Technology Targeted polymerized liposomes for improved drug delivery
WO1996007102A1 (en) * 1994-09-01 1996-03-07 Wisconsin Alumni Research Foundation Therapeutic remodeling in aids
US6060082A (en) * 1997-04-18 2000-05-09 Massachusetts Institute Of Technology Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
AUPO732997A0 (en) * 1997-06-12 1997-07-03 Csl Limited Ganglioside immunostimulating complexes and uses thereof
US5993852A (en) * 1997-08-29 1999-11-30 Pharmaderm Laboratories Ltd. Biphasic lipid vesicle composition for transdermal administration of an immunogen
US6027731A (en) * 1998-11-17 2000-02-22 Wisconsin Alumni Research Foundation Pertussis toxin induced lymphocytosis
JP4685350B2 (ja) * 2001-07-26 2011-05-18 オタゴ イノベイション リミティド 抗原性組成物
JP2009510032A (ja) * 2005-09-30 2009-03-12 リポクセン テクノロジーズ リミテッド 多糖抗原及びタンパク質アジュバントを含む多価リポソームワクチン組成物
RU2480479C1 (ru) * 2011-11-01 2013-04-27 Елена Викторовна Свирщевская Гетерологичный пептидный мини-антиген в составе полимерной частицы для создания противоаллергенной вакцины
DK2800762T3 (en) 2012-01-03 2018-04-16 Us Health NATIVE AND AGONISTIC CTL EPITOPES OF THE MUC1 TUMOR ANTIGEN
EP3412304A3 (en) 2013-10-23 2019-03-20 The United States of America, as represented by The Secretary, Department of Health and Human Services Hla-a24 agonist epitopes of muc1-c oncoprotein and compositions and methods of use
EP3331554B1 (en) 2015-08-03 2022-05-11 The U.S.A. as represented by the Secretary, Department of Health and Human Services Brachyury deletion mutants, non-yeast vectors encoding brachyury deletion mutants, and their use
AU2017355564B2 (en) 2016-11-07 2022-04-14 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Development of agonist epitopes of the human papillomavirus
WO2020102404A1 (en) 2018-11-14 2020-05-22 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Tp5, a peptide inhibitor of aberrant and hyperactive cdk5/p25 as treatment for cancer
EP4093432A1 (en) 2020-01-21 2022-11-30 The United States of America, as represented by the Secretary, Department of Health and Human Services Human immunogenic epitopes of hemo and hhla2 human endogenous retroviruses (hervs)
WO2021150713A2 (en) 2020-01-21 2021-07-29 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Human immunogenic epitopes of h, k, and e human endogenous retroviruses (hervs)

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2009343C3 (de) * 1970-02-27 1980-10-23 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen Verwendung von Lysolecithinen als immunologische Adjuvantien
GB1502774A (en) * 1974-06-25 1978-03-01 Nat Res Dev Immunological preparations
US4196191A (en) * 1975-09-29 1980-04-01 Burroughs Wellcome Co. Biological preparations
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
GB2026340B (en) * 1978-07-03 1982-12-22 Ash P Stabilising microvesicles
US4199565A (en) * 1979-03-26 1980-04-22 Merck & Co., Inc. Liposome particle containing viral or bacterial antigenic subunit
HU184141B (en) * 1979-12-27 1984-07-30 Human Oltoanyagtermelo Adjuvant particles compositions containing said particles and biologically active substances adsorbed thereon and a process for the preparation thereof
US4673574A (en) * 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
US4902506A (en) * 1983-07-05 1990-02-20 The University Of Rochester Immunogenic conjugates
US4761283A (en) * 1983-07-05 1988-08-02 The University Of Rochester Immunogenic conjugates
US4565696A (en) * 1983-08-03 1986-01-21 The Regents Of The University Of California Production of immunogens by antigen conjugation to liposomes
US4708933A (en) * 1984-06-12 1987-11-24 Leaf Huang Immunoliposome assay-methods and products
JPH0832637B2 (ja) * 1985-02-14 1996-03-29 アクゾ・エヌ・ヴエー 合成免疫原
US4797285A (en) * 1985-12-06 1989-01-10 Yissum Research And Development Company Of The Hebrew University Of Jerusalem Lipsome/anthraquinone drug composition and method
US4882145A (en) * 1986-12-09 1989-11-21 Scripps Clinic And Research Foundation T cell epitopes of the hepatitis B virus nucleocapsid protein
EP0306912A3 (en) * 1987-09-08 1989-07-05 Albany Medical College Immunogenic composites capable of selectively inducing antibody production and pharmaceutical compositions employing the same.

Similar Documents

Publication Publication Date Title
RU93004915A (ru) Липосомы, осуществляющие тимус-зависимую помощь "слабым" антигенам, используемым для приготовления вакцины
CA2088163A1 (en) Liposomes that provide thymic dependent help to weak vaccine antigens
IT8822145A0 (it) Vaccini contenenti antigeni tumorali e coadiuvanti e relativo procedimento di preparazione
CA2143823A1 (en) Retro-, inverso - and retro-inverso synthetic peptide analogues
EP0284587A3 (en) Synthetic peptide antigens for the detection of hiv-1 infection
FR2557458B1 (fr) Nouveaux anticorps capables de reconnaitre specifiquement des groupements hapteniques, leur preparation et leur application, et nouveaux antigenes permettant de les preparer
DE3872754D1 (de) Nachweis von antikoerpern humaner immundefizienz-viren.
NZ189756A (en) Muramyl peptides antigens covalently bonded to muramyl-peptides medicaments and vaccines
IL62913A (en) Isolation of glycoproteic antigens of a virus and the preparation of a vaccine from such antigens
KR890700683A (ko) 인체 면역 결핍 바이러스에 대한 항체 검색 방법
ATE2048T1 (de) Isolierung von hepatitis be-antigen.
ATE109004T1 (de) Toleranzinduktion gegenüber einem fremdantigen.
RU96119399A (ru) Иммуномодулирующее лекарственное средство
ITRM910385A0 (it) Vaccini utilizzanti eritrociti come veicoli di antigeni.
NO882865D0 (no) Fremgangsmaate for fremstilling av et emulsjon-sprengstoff.
WO1990015132A3 (en) Cloned treponema hyodysenteriae endoflagellar antigen
IT8205149A0 (it) Procedimento per la preparazione di bevande calde mediante l'uso preferibilmente di sostanze solubili o liofilizzate.
IT8919110A0 (it) Peptidi sintetici e loro uso come carriers universali per la preparazione di coniugati immunogenici adatti per lo sviluppo di vaccini sintetici.
IT8205149A1 (it) Procedimento per la preparazione di bevande calde mediante l'uso preferibilmente di sostanze solubili o liofilizzate.
KR860008779A (ko) 항체 형성 화합물의 제조방법
BR7902674A (pt) Colhedeira de cafe com sistema de succao e vibracao atraves de grampos que abrem e fecham
HK57497A (en) Synthetic antigens for the detection of antibodies to hepatitis C virus
BR8902127A (pt) Sistema pre-emulsificador utilizado no preparo de emulsoes combustiveis e processo de pre-emulsificacao utilizando referido sistema
IT8922409A0 (it) Peptidi sintetici e loro uso come carriers universali per la preparazione di coniugati immunogenici adatti per lo sviluppo di vaccini sintetici
IT8247648A0 (it) Composizione copolimerica antigengi vite e procedimento di preparazione